Recombinant Schizosaccharomyces japonicus Protein sey1 (sey1)

What cellular functions has sey1 been associated with in recent research?

Recent research has identified several key cellular functions of sey1:

• ER Membrane Fusion: As a dynamin-like GTPase, sey1 is implicated in homotypic fusion of endoplasmic reticulum (ER) membranes, playing a crucial role in maintaining ER architecture .

• Lipid Droplet Dynamics: Sey1 has been found to localize to lipid droplets (LDs) and mediate LD recruitment to Legionella-containing vacuoles (LCVs) during Legionella pneumophila infection .

• GTP-Dependent Membrane Interactions: Experimental evidence suggests that sey1's interactions with cellular membranes are GTP-dependent, with GTP hydrolysis powering conformational changes that enable membrane fusion events .

• Pathogen-Host Interactions: Studies in Dictyostelium discoideum have shown that sey1 contributes to LCV expansion and intracellular replication of L. pneumophila, indicating its role in pathogen-host interactions .

• Potential Drug Target: Recent research has identified sey1 as a possible biological target for antimalarial drugs, specifically the imidazolopiperazine compound GNF179, which can inhibit sey1's GTPase activity .

Deletion of sey1 has been shown to result in pleiotropic phenotypes, including altered ER architecture, impaired lysosomal enzyme exocytosis, reduced intracellular proteolysis, and decreased cell motility, highlighting its importance in multiple cellular pathways .

How is recombinant sey1 protein typically expressed and purified for research purposes?

The expression and purification of recombinant sey1 protein typically follows a standardized protocol optimized for this large GTPase:

Expression System:

• Most commonly expressed in E. coli expression systems

• The full-length protein (amino acids 1-764) is typically fused to an N-terminal His tag to facilitate purification

Purification Process:

• Affinity Chromatography: His-tagged sey1 is initially purified using nickel or cobalt affinity chromatography

• Size Exclusion Chromatography: Further purification is achieved through gel filtration to separate the protein from aggregates and contaminants

• Buffer Exchange: The protein is typically exchanged into a Tris/PBS-based storage buffer with 6% trehalose at pH 8.0

Quality Control:

• Purity assessment via SDS-PAGE (typically >90% purity is required for functional studies)

• Western blot confirmation using anti-His antibodies

• Functional assays to confirm GTPase activity

Yield and Storage:

• Final product is typically provided as a lyophilized powder

• For long-term storage, reconstitution in deionized sterile water to 0.1-1.0 mg/mL with 5-50% glycerol (final concentration) is recommended

• Aliquoting and storage at -20°C/-80°C prevents degradation from freeze-thaw cycles

What are the optimal storage and handling conditions for recombinant sey1 protein?

Proper storage and handling of recombinant sey1 protein is critical for maintaining its structural integrity and functional activity:

Storage Recommendations:

Handling Guidelines:

• Centrifuge vials briefly before opening to bring contents to the bottom

• Reconstitute lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Add glycerol to a final concentration of 5-50% before aliquoting

• Store working aliquots at 4°C for up to one week

• Avoid repeated freeze-thaw cycles as they significantly reduce protein activity

Important Considerations:

• For short-term experiments, maintain working aliquots at 4°C rather than subjecting the protein to multiple freeze-thaw cycles

• When thawing frozen aliquots, use rapid thawing at room temperature followed by immediate transfer to ice

• Monitor protein integrity over time using activity assays if stored for extended periods

How does the GTPase activity of sey1 contribute to its cellular functions?

The GTPase activity of sey1 is central to its biological functions through a mechanistic cycle that powers its membrane fusion and remodeling activities:

GTPase Domain Structure and Function:

• The catalytic GTPase domain contains highly conserved motifs: P-loop, Walker A, Walker B, and guanosine-binding sites

• These motifs coordinate GTP binding and hydrolysis, converting chemical energy into mechanical force

Mechanistic Cycle:

• GTP Binding: Induces conformational changes that promote sey1 oligomerization

• Oligomerization: Enables tethering of opposing membranes (e.g., ER tubules)

• GTP Hydrolysis: Triggers power stroke that brings membranes into close proximity

• Phosphate Release: Results in conformational rearrangement that promotes membrane fusion

• GDP Release: Resets the protein for another cycle

Experimental Evidence:

• GTP addition stimulates sey1-mediated interactions between cellular structures such as LDs and LCVs

• Inhibition of sey1's GTPase activity by compounds like GNF179 prevents its normal function in membrane dynamics

• Surface plasmon resonance experiments demonstrate direct binding of GTP analogs to the GTPase domain

Functional Implications:

• Deletion of sey1 disrupts ER architecture due to impaired homotypic fusion of ER tubules

• Mutations in GTP-binding motifs render the protein non-functional, highlighting the essential nature of this activity

• The GTPase activity provides a druggable target for therapeutic intervention, as demonstrated by antimalarial research

What experimental approaches can be used to study sey1's role in lipid droplet dynamics?

Multiple complementary experimental approaches can be employed to investigate sey1's role in lipid droplet (LD) dynamics:

Cellular and Biochemical Approaches:

• Subcellular Fractionation and Proteomics:

  • Isolation of purified LDs followed by mass spectrometry to confirm sey1 localization

  • Comparative proteomics between wild-type and Δsey1 mutant LD fractions to identify changes in LD-associated proteins

• Fluorescence Microscopy:

  • GFP-tagged sey1 constructs to visualize subcellular localization

  • Co-localization with LD markers (e.g., PLIN)

  • Live-cell imaging to track dynamic interactions between sey1-positive structures and LDs

• In vitro Reconstitution Assays:

  • Purified LDs and recombinant sey1 protein to assess direct interactions

  • GTP-dependency tests using non-hydrolyzable GTP analogs or GTPase-deficient sey1 mutants

  • Membrane fusion assays using fluorescently-labeled synthetic membranes

Genetic and Molecular Approaches:

• Gene Knockout/Knockdown Studies:

  • Generation of sey1-deficient cell lines to study effects on LD number, size, and composition

  • Phenotypic rescue experiments with wild-type or mutant sey1 constructs

• Domain Analysis:

  • Truncation or point mutation constructs to identify domains required for LD association

  • Chimeric proteins to investigate domain-specific functions

• Lipid Analysis:

  • Lipidomics comparison between LDs isolated from wild-type and Δsey1 cells

  • Analysis of fatty acid content and phospholipid composition of LDs

Infection Models:

• Legionella pneumophila infection assays in wild-type vs. Δsey1 cells to assess LD-LCV interactions

• Time-course imaging to track LD dynamics during infection

• Assessment of LCV integrity using cytoplasmic markers like mCherry

How does sey1 deletion affect cellular phenotypes across different model organisms?

Deletion of sey1 produces distinct but related phenotypes across different model organisms, reflecting its conserved but contextually nuanced functions:

In Dictyostelium discoideum:

• Altered ER architecture with partial disruption of the tubular ER network

• Preserved macropinocytic and phagocytic functions

• Impaired lysosomal enzyme exocytosis and intracellular proteolysis

• Reduced cell motility and compromised growth on bacterial lawns

• Defective LCV expansion and impaired intracellular replication of Legionella pneumophila

In Yeast Models:

• Fragmented ER morphology

• Defects in ER-ER fusion events

• Synthetic growth defects when combined with mutations in other ER shaping proteins

• Impact on lipid droplet biogenesis and morphology

In Plasmodium Species:

• Altered ER morphology upon inhibition of SEY1

• Compromised parasite viability when SEY1 function is disrupted

• Resistance to certain antimalarial compounds when SEY1 is overexpressed, suggesting a role in drug mechanisms

Cross-Species Comparison Table:

The conserved nature of these phenotypes across evolutionary distance highlights the fundamental importance of sey1 in membrane homeostasis and organelle dynamics, while the variations reflect species-specific adaptations of its function.

What structural features of sey1 make it a potential druggable target?

Several structural characteristics of sey1 contribute to its potential as a druggable target for therapeutic intervention:

Key Druggable Features:

• Well-Defined GTPase Domain:

  • Contains a druggable catalytic region with conserved motifs (P-loop, Walker A, Walker B, and guanosine-binding sites)

  • The nucleotide-binding pocket provides a specific target for small molecule inhibitors

• Structural Conservation:

  • High degree of structural conservation across species, as demonstrated by the mirror symmetry between Plasmodium falciparum SEY1 and Candida albicans SEY1 models

  • Conserved structure facilitates cross-species drug development while allowing for selective targeting

• Essential Cellular Function:

  • Plays crucial roles in ER membrane dynamics and lipid droplet function

  • Deletion or inhibition produces significant cellular phenotypes, suggesting therapeutic potential

• Demonstrated Binding to Small Molecules:

  • Research has shown that compounds like GNF179 can bind to and inhibit SEY1 GTPase activity

  • Surface plasmon resonance experiments demonstrated elevated levels of GNF179 on PvSEY1-coated sensor chips

Experimental Evidence for Druggability:

• Molecular docking studies predict binding of inhibitors to conserved GTPase motifs

• Thermal shift assays show that GNF179 reduces PvSEY1 melting temperature, indicating direct interaction

• Functional studies confirm that GNF179 inhibits PvSEY1 GTPase activity

• Genetic studies demonstrate that Plasmodium SEY1 overexpression confers resistance to GNF179, further supporting SEY1 as the drug target

The combination of a well-defined catalytic domain, structural conservation, essential function, and experimental validation makes sey1 a compelling target for drug development, particularly in the context of antimalarial therapeutics.

How can researchers assess the functional integrity of recombinant sey1 protein in vitro?

Multiple complementary assays can be employed to verify the functional integrity of recombinant sey1 protein:

Biochemical Activity Assays:

• GTPase Activity Assay:

  • Colorimetric measurement of phosphate release using malachite green

  • HPLC-based detection of GDP formation from GTP

  • Real-time monitoring using fluorescent GTP analogs

• Nucleotide Binding Assays:

  • Isothermal titration calorimetry (ITC) to measure thermodynamic parameters of GTP binding

  • Fluorescence-based assays using MANT-GTP or similar fluorescent nucleotide analogs

  • Surface plasmon resonance to measure real-time binding kinetics

Structural Integrity Assessments:

• Thermal Shift Assays:

  • Differential scanning fluorimetry to determine protein stability and detect ligand binding

  • Changes in melting temperature upon addition of nucleotides or potential inhibitors

• Limited Proteolysis:

  • Exposure to proteases followed by SDS-PAGE analysis to assess proper folding

  • Properly folded proteins show characteristic digestion patterns

• Circular Dichroism Spectroscopy:

  • Assessment of secondary structure content

  • Monitoring of thermal unfolding to determine stability

Functional Membrane Interaction Assays:

• Liposome Tubulation/Fusion Assays:

  • Mixing of fluorescently labeled liposomes with recombinant sey1 to assess fusion activity

  • Electron microscopy visualization of membrane morphology changes

• GTP-Dependent Oligomerization:

  • Size exclusion chromatography to detect GTP-induced oligomeric states

  • Dynamic light scattering to measure changes in protein complex size

Validation Protocol Flowchart:

• Initial purity assessment (SDS-PAGE, >90% purity)

• Basic structural integrity (CD spectroscopy, thermal shift baseline)

• Nucleotide binding capacity (ITC or fluorescence-based assay)

• GTPase activity measurement (phosphate release assay)

• Membrane interaction studies (liposome assays)

These assays collectively provide a comprehensive assessment of recombinant sey1's functional integrity, ensuring that the protein maintains its native properties and activities for downstream applications.

What are the current contradictions or knowledge gaps in sey1 research?

Despite significant advances in understanding sey1 function, several important contradictions and knowledge gaps remain in the field:

Structural Uncertainties:

• Complete atomic-resolution structure of full-length sey1 including transmembrane domains remains unresolved

• Structural changes during the GTPase cycle are incompletely characterized

• Molecular details of how sey1 mediates membrane fusion remain debated

Functional Ambiguities:

• Lipid Droplet Association:

  • Direct evidence for sey1 localization to LDs shows some inconsistencies across studies

  • The mechanism by which sey1 mediates LD-LCV interactions remains unclear

  • Whether sey1 directly associates with LDs or influences them indirectly via ER contacts is unresolved

• GTPase Regulation:

  • Factors that regulate sey1 GTPase activity in vivo are poorly characterized

  • Whether sey1 requires cofactors or binding partners for optimal activity is not fully established

  • The rate-limiting step in the GTPase cycle remains debated

• Drug Targeting Mechanism:

  • While evidence suggests SEY1 as a target for compounds like GNF179, the precise binding mode and inhibition mechanism require further characterization

  • The selectivity of inhibitors between host and pathogen SEY1 orthologs needs clarification

Methodological Challenges:

• Protein Purification:

  • Obtaining full-length, properly folded sey1 with intact transmembrane domains remains technically challenging

  • Reconstitution into membrane systems while maintaining activity presents difficulties

• In Vivo Analysis:

  • Distinguishing direct vs. indirect effects of sey1 deletion is complicated by its fundamental role in ER function

  • The pleiotropic effects of sey1 deletion make it difficult to isolate specific functional pathways

Future Research Directions:

• Development of conditional/inducible knockouts to better dissect temporal requirements for sey1

• Creation of separation-of-function mutants to distinguish different aspects of sey1 activity

• Advanced imaging techniques to track sey1 dynamics in real-time

• Comprehensive interactome analysis to identify sey1 binding partners and regulators

Addressing these knowledge gaps will require interdisciplinary approaches combining structural biology, biochemistry, cell biology, and genetics to fully elucidate the complex functions of this essential GTPase.

How can researchers utilize recombinant sey1 protein to study membrane fusion mechanisms?

Recombinant sey1 protein provides a powerful tool for investigating membrane fusion mechanisms through various experimental approaches:

In Vitro Reconstitution Systems:

• Minimal Membrane Fusion Assays:

  • Purified recombinant sey1 incorporated into synthetic liposomes

  • Fluorescence dequenching assays using lipid-mixing indicators (e.g., NBD-PE/Rh-PE pairs)

  • Content-mixing assays using self-quenching fluorophores to distinguish hemifusion from full fusion

• Real-time Visualization:

  • Total internal reflection fluorescence (TIRF) microscopy to observe single fusion events

  • High-speed atomic force microscopy to track membrane topological changes

  • Cryo-electron microscopy to capture fusion intermediates

Structure-Function Analysis:

• Mutational Studies:

  • Systematic mutagenesis of GTPase domain residues to identify critical amino acids

  • Creation of GTPase-deficient mutants (e.g., K/A mutations in P-loop)

  • Transmembrane domain alterations to assess membrane anchoring requirements

• Domain Swapping:

  • Chimeric constructs with other dynamin-like proteins to identify fusion-specific domains

  • Minimal domain constructs to determine sufficiency for membrane interactions

Regulatory Mechanism Investigation:

• GTPase Cycle Manipulation:

  • Use of non-hydrolyzable GTP analogs (GTPγS, GMPPNP) to trap specific conformational states

  • GDP-AlF₄⁻ to mimic the transition state of GTP hydrolysis

  • Comparison of GTP- vs. GDP-bound states to elucidate conformational changes

• Interacting Partner Assessment:

  • Co-reconstitution with candidate regulatory proteins

  • Pull-down assays using recombinant sey1 as bait to identify novel interactors

  • Competition assays to map binding interfaces

These approaches collectively provide a comprehensive toolkit for dissecting the molecular mechanisms of sey1-mediated membrane fusion, allowing researchers to bridge structural insights with functional outcomes in this essential cellular process.

What considerations should be made when designing experiments to study sey1 interactions with lipid droplets?

When investigating sey1 interactions with lipid droplets, researchers should consider several critical experimental design factors:

Sample Preparation Considerations:

• Lipid Droplet Isolation:

  • Purity assessment is crucial to avoid contamination with other membrane structures

  • Documentation of purification steps with clear visualization of enrichment process

  • Validation of LD markers (e.g., PLIN) at each purification stage

• Cell Culture Conditions:

  • Consider lipid loading protocols (e.g., palmitate supplementation) that may affect results

  • Be aware that continuous treatment with high concentrations of palmitate (e.g., 200μM) may introduce artifacts not present in normal cellular conditions

  • Include appropriate controls to distinguish physiological from pathological states

Technical Approach Selection:

• Direct vs. Indirect Interactions:

  • Differentiate between direct sey1-LD binding and indirect effects through ER-LD contacts

  • Use multiple complementary approaches (biochemical, imaging, genetic) to corroborate findings

  • Consider proximity labeling approaches (BioID, APEX) to identify proteins in close proximity to sey1

• Resolution Limitations:

  • Be aware that standard confocal microscopy may not resolve ER-LD contact sites from LD localization

  • Consider super-resolution techniques (STED, PALM/STORM) or electron microscopy for definitive localization

  • Use appropriate controls for fluorescent protein fusions that may affect localization

Experimental Controls and Validations:

• Protein Expression Levels:

  • Overexpression artifacts can lead to mislocalization

  • Use endogenous tagging approaches when possible

  • Validate findings with antibodies against native protein (when available)

• Functional Validation:

  • Complement localization studies with functional assays

  • Consider lipid composition analysis of LDs from wild-type vs. Δsey1 cells

  • Perform rescue experiments with wild-type sey1 and specific mutants

• Alternative Hypotheses Testing:

  • Test competing explanations for observed phenotypes

  • For example, assess LCV integrity during L. pneumophila infection to rule out that LD localization is only with damaged LCVs

  • Use markers like cytoplasmic mCherry to evaluate membrane integrity

By carefully addressing these considerations, researchers can obtain more reliable and physiologically relevant insights into the complex relationship between sey1 and lipid droplet dynamics, avoiding common pitfalls that have led to contradictory findings in the literature.